Waldemar Priebe
Profile
Waldemar Priebe is the founder of Reata Pharmaceuticals, Inc. (founded in 2002), Moleculin Biotech, Inc. (founded in 2015), and CNS Pharmaceuticals, Inc. (founded in 2017).
Former positions of Waldemar Priebe
| Companies | Position | End |
|---|---|---|
| MOLECULIN BIOTECH, INC. | Founder | - |
| CNS PHARMACEUTICALS, INC. | Founder | - |
| REATA PHARMACEUTICALS, INC. | Founder | - |
Experiences
Positions held
Linked companies
| Listed companies | 2 |
|---|---|
| MOLECULIN BIOTECH, INC. | Health Technology |
| CNS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
- Stock Market
- Insiders
- Waldemar Priebe
